RECURSION PHARMACEUTICALS IN's ticker is and the CUSIP is 75629V904. A total of 4 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $760 | +248.6% | 99,400 | +239.2% | 0.00% | – |
| Q2 2023 | $218 | +220.6% | 29,300 | +187.3% | 0.00% | – |
| Q1 2023 | $68 | +3300.0% | 10,200 | +3300.0% | 0.00% | – |
| Q4 2022 | $2 | -100.0% | 300 | -92.7% | 0.00% | – |
| Q3 2022 | $43,000 | -10.4% | 4,100 | -31.7% | 0.00% | – |
| Q2 2022 | $48,000 | -71.8% | 6,000 | -74.8% | 0.00% | – |
| Q1 2022 | $170,000 | +220.8% | 23,800 | +667.7% | 0.00% | – |
| Q4 2021 | $53,000 | +1666.7% | 3,100 | +3000.0% | 0.00% | – |
| Q3 2021 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 128,000 | $979,200 | 0.00% |
| SIMPLEX TRADING, LLC | 99,400 | $760 | 0.00% |
| JANE STREET GROUP, LLC | 118,500 | $906,525 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |